Abbreviations: CW, Comano's thermal water; DW, deionised water; IL-8, interleukin-8; sIL-8, secreted IL-8; TNF-α, tumour necrosis factor-α, WB, Western immunoblotting.
Introduction
Psoriasis, a chronic inflammatory dermatosis affecting about 2% of the Western population, is clinically marked by relapsing-remitting manifestations of well-defined, symmetrical erythematous plaques covered by scales. Albeit genetically founded, the pathogenesis of psoriasis remains unclear (1) . Currently, psoriasis is believed to be a T lymphocyte-driven disorder (2) .
However, the formation of tortuous, dilated, inflamed, and hyper-permeable venous limbs of capillary plexuses in the upper dermal papillae precedes the plaque's epidermal hyperplasia and dermal infiltration by inflammatory cells (i.e. neutrophils, T lymphocytes, monocytes) (3) (4) (5) (6) . This has suggested that psoriasis is an angioproliferative ailment due to the local release of angiogenic molecules by the epidermis (7) (8) (9) (10) . Local fibroblast activation and increased keratinocytes' production and release of several cytokines/chemokines, such as interleukin-1 (IL-1), tumour necrosis factor-α (TNF-α), IL-6, IL-8, IL-20, vascular endothelial growth factor-A (VEGF-A) isoforms, endothelial cell stimulating angiogenesis factor (ESAF), transforming growth factor-α (TGF-α), amphiregulin, platelet-derived endothelial cell growth factor/thymidine phosphorylase (TP) are also typical features of the disease (9, (11) (12) (13) (14) (15) (16) (17) (18) .
Several lines of evidence indicate that IL-8 is a C-X-C chemokine partaking to the psoriatic cytokine network (15, (19) (20) (21) (22) (23) (24) and being thus involved in the pathogenesis of psoriasis (15, (19) (20) (21) (22) (23) (24) (25) (26) . In psoriasis, IL-8 acts as a factor promoting epidermal hyperplasia (27) , as a strong chemo-attractant for T lymphocytes, neutrophils, basophils, and mastcells (28) (29) (30) (31) (32) , and as a stimulant of dermal neo-angiogenesis (20) . Psoriatic lesional skin contains high amounts of IL-8 mRNA and protein (19, 22, 24, 25) . IL-8 synthesis on the part of epidermal, dermal and infiltrating inflammatory cells is stimulated by several cytokines, like IL-1, TNF-α, GM-CSF, and IFN-γ (19, 26, 33) . However, keratinocytes and neutrophils are IL-8's main sources (22, 24) . A heightened expression of IL-8's receptor also occurs in psoriatic lesional epidermis (23, 26) . Thus, an autocrine loop involving IL-8 and its receptor favours the setting off of the psoriatic epidermal hyperplasia (26, 27) . Serum levels of IL-8, like those of TNF-α, IL-6, IL-12, IL-18 and IFN-γ, are much higher in patients with active psoriasis than in healthy controls (34, 35) .
As mentioned above, psoriatic lesional skin over-expresses TNF-α, a key cytokine involved in the pathogenetic mechanisms sustaining several inflammatory skin illnesses (12, 15, 20, 33, (35) (36) (37) (38) . Resident dermal cells (fibroblasts, mast-cells) and infiltrated antigenpresenting cells (APCs), macrophages, and T lymphocytes also express TNF-α (38) . The earlyoccurring TNF-α over-production and hyper-secretion in psoriasis vulgaris, in its recalcitrant generalised pustular (von Zumbusch) type (39) (40) (41) favours the cellular infiltration of epidermal and dermal layers by eliciting the expression of intercellular adhesion molecules like ICAM-1, V-CAM-1, and E-selectin by the keratinocytes and endothelial cells (42) . In synergism with IFN-γ and IL-1, TNF-α  acts as a pro-inflammatory agent by up-regulating cytokines/chemokines like IL-8 (19, 20, 43) , IL-6, IL-1, leukemia inhibitory factor (LIF), GM-CSF (43) , and TGF-α (19).
Moreover, TNF-α stimulates the production of arachidonate cascade derivatives like leukotriene B 4 (LTB 4 ) and prostaglandin E 2 (PGE 2 ), and of oxygen radicals (superoxide anions) (43) . In its own turn, TNF-α expression is up-regulated by several cytokines, like IL-1, IL-2, GM-CSF, and
IFN-γ (43).
Comano (Trentino, Italy) spa's water (CW) is a thermal hypotonic water containing various electrolytes (see Table I ). The major dermatological diseases so far treated via CW balneotherapy are psoriasis and atopic dermatitis (44) . Other dermatoses also cared for with CW include contact dermatitis, seborrhoeic dermatitis, lichen planus, and palmo-plantar keratosis (44) . Previous in vivo studies showed the effectiveness of CW balneotherapy in the treatment of psoriasis, since it both significantly lessened hyper-keratosis, acantosis, and dermal papillomatosis and improved skin hydration (44) . It must be recalled here that the permeability barrier of normal epidermis is severely disturbed in psoriatic skin (45) (46) (47) , and that bathing in hypotonic salt solutions triggers anti-inflammatory effects in lesional skin sites (48) . However, most of the mechanisms through which the clinical signs of psoriasis (and of the other above mentioned skin disorders) are improved by means of CW balneotherapy have not as yet been clarified.
In previous works (49, 50) , we showed that exposure to CW interferes with IL-6, VEGF-A isoform, and CK-16 expression by human psoriatic keratinocytes. To further clarify the mechanisms involved in the therapeutic effectiveness of CW balneotherapy in psoriasis, in this work we investigated CW's effects on TNF-α and IL-8 production and secretion by epidermal keratinocytes isolated from lesional skin biopsies and kept in confluent cultures. Here, we will show that the addition of CW (in total or partial stead of DW) to the growth medium remarkably hinders the hyper-expression of TNF-α and the heightened production and release of IL-8 on the part of the psoriatic keratinocytes. Therefore, our previous (49, 50) and present findings are consistent with CW being endowed with a complex phenotype-and cytokine/chemokineregulating potential that translates into valuable anti-psoriatic therapeutic benefits.
Materials and methods
In vitro cell culture. For this work human epidermal keratinocytes were isolated from skin biopsies taken, after informed consent, from 9 psoriatic patients. After rapidly reaching the laboratory, the biopsies were incubated at 4 °C overnight in a dispase II solution (0.25% w/v; Roche, Milan, Italy). Weak enzymatic digestion allowed the epidermis (as a single lamina) to easily detach from the underlying dermis and subcutaneous tissue. By incubating the isolated epidermal sheet in trypsin solutions (0.25% w/v), suspensions of keratinocytes obtained.
Trypsin's action was next inhibited by adding an excess of serum, and the cell suspensions were soon spun down at 600 rpm for 10 min at 4°C. The supernatants were decanted, the pellets 
Results

CW's effects of on intracellular levels of IL-8. WB analyses revealed that human psoriatic
keratinocytes produced an IL-8 precursor endowed with a molecular mass of 51 kDa (Fig. 1B) (53). Both confocal microscopy (Fig. 1A) , WB observations (Fig. 1B) , and densitometric determinations (Fig. 1C) showed that by days 3 and 5 after the onset of the experiments in the 100% CW-DMEM-incubated keratinocytes the intracellular levels of IL-8 had significantly fallen (in WB specimens: at day 3, -86%, p<0.001; at day 5, -76%, p<0.001) with respect to the DW-DMEM-kept (untreated) cells. Next, at day 7, intracellular IL-8 levels became alike in both CWtreated and untreated keratinocytes (Fig. 1A-C) , possibly because the untreated cells kept dumping significant amounts of IL-8 into the medium (Fig. 2) . Finally, by day 11, in CW-DMEM-kept keratinocytes intracellular IL-8 levels were found to have risen 3.9-fold (p<0.001 in WB specimens) with respect to 7-day values, thus becoming 3-fold higher (p<0.001) than in DW-DMEM-incubated cells (Fig. 1A-C) . Thus incubating keratinocytes in CW-DMEM medium brought about an early deep cutback followed by a belated intracellular surge of intracellular IL-8 levels.
As assessed from the values of the surface areas under the respective curves in Fig. 1C , between days 3 and 11, total IL-8 levels in CW-DMEM-exposed keratinocytes were by 56% lower (p<0.001) than in their DW-DMEM-kept counterparts. Conceivably, these observations were the result of an early remarkable and persistent down-regulation of IL-8 production, onto which a progressively stronger hindrance of IL-8 secretion was lately superimposed (see below).
CW's effects on IL-8 secretion.
When untreated (i.e. incubated in DW-DMEM), the psoriatic keratinocytes released from the third day onwards growing amounts of IL-8 (up to 3.8 ng ml -1 per containing various percent (i.e. from 25% to 100%) CW fractions, the IL-8-secreting activity was strikingly and progressively cut down from day 6 onwards (for example, at day 8, from -38% to -54%, p<0.001; and at day 13, from -74% to -87%, p<0.001 vs. parallel untreated controls in both instances) (Fig. 2) . Most interesting, a nearly maximum inhibitory effect on IL-8 secretion could be achieved by keeping keratinocytes in a CW 25%/DW 75%-DMEM (Fig. 2) . Hence, as assessed from the values of the surface areas under the respective curves in Fig. 2 , an exposure between days 3 and 13 to CW fractions ranging from 25% to 100% in the DMEM similarly reduced from -47% to -51% (p<0.001) the total amount of secreted IL-8 (sIL-8) with respect to that dumped by untreated keratinocytes into the DW-DMEM.
CW's effects of on TNF-α expression and secretion. The results of preliminary WB observations
and of corresponding densitometric assessments showed that after a 5-day exposure to 100% CW-DMEM, the density of the TNF-α-specific 45 kDa protein band had diminished by -66.3%
(p<0.001) with respect to that of parallel DW-DMEM-incubated keratinocytes (Fig. 3A,B) .
Moreover, a 7-day exposure to 100% CW-DMEM elicited the utmost decrease in the density of the TNF-α-specific protein band (day 7, -72.9%; p<0.001) vs. that of time-corresponding DW-DMEM-kept keratinocytes (Fig. 3A,B) . By day 11 CW-treated keratinocytes were found to express TNF-α moieties again at the day 5 levels, which were still 44% lower than those of their untreated (DW-DMEM-kept) parallel counterparts (Fig. 3A,B) . Therefore, as assessed from the values of the surface areas under the respective curves in Fig. 3B , between days 3 and 11 the exposure to CW curtailed by -54% (p<0.001) the total expression of TNF-α by cultured human epidermal keratinocytes with respect to untreated DW-DMEM-kept counterparts.
On the other hand, by using a TNF-α−specific ELISA assays we were unable to detect any measurable amount whatsoever of secreted TNF-α in any of the keratinocyte-conditioned samples of DW-or CW-DMEM media tested (not shown).
Discussion
In this work, we tested CW's effects on the up-regulated production and secretion of IL-8 on the part of psoriatic keratinocytes kept in pure in vitro cultures, i.e. in the complete absence of T cells (54) . Our findings show that the addition of CW (instead of DW) to the DMEM significantly curtailed both the heightened intracellular levels and secretion rates of IL-8 by these cells. Notably, IL-8 hyper-secretion was cut down by incubating the psoriatic keratinocytes in a DMEM whose CW fraction was as little as 25%. This increasingly effective inhibition of IL-8 release by CW went so far as to elicit a late discrete intracellular IL-8 accumulation notwithstanding that its production had concurrently been down-regulated. The operative mechanisms underlying these IL-8-interfering effects elicited by CW components in psoriatic keratinocytes remain to be elucidated. Nuclear factor (NF)-κB is a transcription factor that modulates the expression of genes encoding cytokines like IL-8, IL-6, colony stimulating factors, adhesion molecules, and immune receptors (55) . Notably, TNF-α partakes to the activation of NF-κB, thereby acting as a significant modulator of the expression of several pro-inflammatory compounds in psoriasis (12, 15, 19) .
In keeping with this view, the present results show that CW exposure also significantly interferes with the expression of TNF-α by the cultured psoriatic keratinocytes. Hence, it seems conceivable to ascribe the previously observed CW's interfering effects on IL-6 production and secretion (50) and the presently reported CW's hindering of IL-8 synthesis and release to an upstream inhibition of TNF-α expression by the same CW components.
It is well established that TNF-α plays a major role in psoriasis pathogenesis and progression (40) . Clinical improvements of psoriasis associate with a fall in lesional skin and serum TNF-α levels (36, 56, 57) , whereas clinical aggravations of psoriatic area severity index (PASI) scores concur with surges in serum and lesional skin TNF-α concentrations (40, 60) . On the other hand, it is conceivable to ascribe the observed absence of any TNF-α secretion by the cultured psoriatic keratinocytes to a lack of activity on the part of the TNF-α converting enzyme (TACE) in such cells (62, 63) . TACE, also named ADAM 17, is a member of a disintegrin and metalloproteinase (ADAM) family of proteinases and its mRNA is hyperexpressed in lesional psoriatic skin and in cultured normal keratinocytes (63) (64) (65) 
